Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved ...
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results